Clydesdale Pharma is established in 2019, with the objective to distribute generic products in the United Kingdom. Ever since the company has acquired over 40 generic products and are currently distributing them in the country as well as exporting them outside of the United Kingdom. The company's portfolio continues to grow to bring new generic products to the market.
Clydesdale Pharma operates from its headquarter in Hampshire where the company own its MHRA approved GMP and GDP facility to perform batch testing, release and distribution of products to the UK market.
Our mission is to become the preferred partner with pharmaceutical companies, to deliver safer and reliable medicinal products. Patient safety is critical to us, that's why we keep our values between creativity and excellence allowing us to deliver high quality services.
Our vision is to become the preferred partner in pharmaceutical sector to deliver safer and reliable medicinal products and services.
We are committed to delivering results you can trust, to consolidate our reputation for excellence.